News
NARI
50.56
+2.68%
1.32
Weekly Report: what happened at NARI last week (1104-1108)?
Weekly Report · 4d ago
Inari Medical, Inc. (NASDAQ:NARI) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable
Simply Wall St · 11/07 12:40
Weekly Report: what happened at NARI last week (1028-1101)?
Weekly Report · 11/04 09:24
Inari Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St · 10/30 12:17
Needham Reiterates Hold on Inari Medical
Benzinga · 10/30 09:50
Inari Medical Breaks Above 200-Day Moving Average - Bullish for NARI
NASDAQ · 10/29 17:47
Inari Medical Price Target Raised to $50.00/Share From $46.00 by Truist Securities
Dow Jones · 10/29 17:31
Inari Medical Is Maintained at Hold by Truist Securities
Dow Jones · 10/29 17:31
Truist Securities Maintains Hold on Inari Medical, Raises Price Target to $50
Benzinga · 10/29 17:21
Inari Medical PEERLESS Results Show Superiority Of FlowTriever Compared To Catheter-Directed Thrombolytics For Intermediate-Risk Pulmonary Embolism, Published In 'Circulation'; PEERLESS Met Its Primary Composite Endpoint
Benzinga · 10/29 16:13
Inari Medical reports PEERLESS study met primary composite endpoint
TipRanks · 10/29 16:06
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday
Benzinga · 10/29 14:47
Inari Medical Up Over 15%, On Track for Largest Percent Increase Since August 2023 -- Data Talk
Dow Jones · 10/29 14:43
Bank of America Securities Remains a Buy on Inari Medical (NARI)
TipRanks · 10/29 14:06
Inari Medical price target raised to $50 from $46 at Truist
TipRanks · 10/29 13:50
INARI MEDICAL SHARES UP 14% AFTER CO RAISES FY2024 REVENUE FORECAST
Reuters · 10/29 13:34
Key Takeaways From Inari Medical Analyst Ratings
Benzinga · 10/29 13:00
INARI MEDICAL INC <NARI.O>: CANACCORD GENUITY RAISES TARGET PRICE TO $74 FROM $71
Reuters · 10/29 12:49
Inari Medical Price Target Raised to $74.00/Share From $71.00 by Canaccord Genuity
Dow Jones · 10/29 12:22
Inari Medical Is Maintained at Buy by Canaccord Genuity
Dow Jones · 10/29 12:22
More
Webull provides a variety of real-time NARI stock news. You can receive the latest news about Inari Medical, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About NARI
Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.